Navigation Links
FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
Date:5/13/2008

DELAND, Fla., May 13 /PRNewswire/ -- USHIFU, LLC, the clinical trial management provider for Focus Surgery, Inc. (Indianapolis, IN), is pleased to announce conditional written approval pending minor changes to the protocol from the FDA to begin a pivotal trial for the treatment of recurrent prostate cancer with the Sonablate(R) 500 in men who have failed external beam radiation therapy.

Dr. Herbert Lepor, Chairman of Urology at NYU School of Medicine and medical monitor for the trial said, "It is my pleasure to serve as the medical monitor for the prostate cancer clinical trial program evaluating the safety and effectiveness of the Sonablate(R) 500 HIFU device."

"I have personally reviewed the preliminary data and observed the Sonablate(R) 500 in action and I am impressed with this advanced technology for ablating the prostate. These rigorous clinical trials will help define the appropriate role of the Sonablate(R) 500 device in the treatment of prostate cancer," Lepor added.

This trial will be conducted at various sites across the U.S. and is expected to enroll approximately 202 subjects and 10 clinical centers. This clinical trial is based on results from the feasibility trial completed in October 2007 which enrolled 11 subjects from two clinical research sites within the U.S. Ten of the eleven subjects had failed external beam radiation therapy prior to participating in the clinical trial. The results of this feasibility trial provided a basis for the pivotal study. Additional studies are still needed to satisfy the safety and effectiveness standards, including long term outcomes, set by the FDA for marketing approval.

The Sonablate(R) 500 is not approved for use in the U.S. The Sonablate(R) 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate(R) 500 for the treatment of prostate canc
'/>"/>

SOURCE USHIFU, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
4. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
7. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
8. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
9. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
10. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
11. Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)...  Four financial reasons to reduce pressure ulcers ... by Leaf Healthcare, Inc . According ... (AHRQ), pressure ulcers cost the US healthcare ... addition to direct treatment related costs, pressure ulcers ... impact hospital performance metrics. On top of the ...
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/4q3mv2/investigation ) ... on China Olmesartan Market, 2010-2019" report to their ... successfully developed by Sankyo Pharmaceuticals Co., Ltd and was ... was approved by FDA to enter the American market ... drug in the world after it succeeded in the ...
(Date:9/3/2015)... Sep. 03, 2015 Research ... of the "Investigation Report on China,s Bromhexine Market, ... air pollution worsens, the incidence of respiratory disease keeps ... drugs. Bromhexine, a semisynthetic derivative of vasicine, is a ... and asthma associated with viscid or excessive mucus. It ...
Breaking Medicine Technology:Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3China Olmesartan Investigation Market Report 2010-2019 2China Bromhexine Market Report 2015-2019 2
(Date:9/3/2015)... , ... September 03, 2015 , ... ... with Amerinet Inc., a leading national healthcare solutions organization, to provide electronic medical ... , Through this agreement, Amerinet members will receive negotiated pricing on E-Volve Health’s ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... made the company the final destination of his six-month, 10,000 mile journey from ... , During the trek—which he calls the “Connecting Las Americas” project—Max crossed six ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Leadership® and Navigant Center for Healthcare Research and Policy Analysis has found physician ... , While 47 percent of respondents said their organizations conduct some ...
(Date:9/3/2015)... ... 03, 2015 , ... Hope For The Warriors® is pleased ... are awarded two times each year to spouses or caregivers of post-9/11 wounded ... to restoring a sense of self, restoring the family unit, and restoring hope ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... for LANDESK Management Suite customers, as part of the LANDESK One Partner ... IT, by delivering the best mobile user experience in remote access and control:, ...
Breaking Medicine News(10 mins):Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4
... most humans couldn,t maintain such a low-cal diet, scientists ... back drastically on daily calorie intake can lead to ... Buffalo researchers. , They speculate that this kind of ... slowing the progression to disability. , A lifelong 40 ...
... Palatin Technologies,Inc. (Amex: PTN ) today announced ... Renshaw 9th Annual Healthcare Conference at the New York ... at 4:45 PM ET. Carl Spana, Ph.D., President ... update on the Company,s corporate and,development programs. To access ...
... effective in patients under 60, study finds , FRIDAY, Nov. ... are just as effective for treating prostate cancer in men ... new study finds. , Brachytherapy is a minimally invasive ... prostate to kill cancer cells. Recovery time after seed implantation ...
... honor Hispanic entrepreneurs in ... Texas with Aflac Civic Awards., ... recognized with an Aflac Civic Award for making a,difference in ... Barreto, chairman of the Latino Coalition and former,administrator of the ...
... Nov. 2 National Infertility Awareness Week is,Nov. 4-10. ... affects one in eight couples in the United States. ... a male or a female,which inhibits the ability to ... inability to conceive after one year of trying with ...
... ... and Long-Term Health, SAN FRANCISCO, ... food products that their scientific evidence and clinical,benefits may often ... clinicians, said presenters at a satellite,symposium during the 2007 meeting ...
Cached Medicine News:Health News:Calorie-Starved Rats Live Longer: Study 2Health News:Radiation Seed Treatment Helps Younger Men Fight Prostate Cancer 2Health News:Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas 2Health News:Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas 3Health News:Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas 4Health News:Updated: National Infertility Awareness Week Nov. 4-10; Infertility Affects Significant Number of Couples 2Health News:Updated: National Infertility Awareness Week Nov. 4-10; Infertility Affects Significant Number of Couples 3Health News:Probiotics Play Critical Role in Pediatric Health and Immunity 2Health News:Probiotics Play Critical Role in Pediatric Health and Immunity 3
Double bent ends prevent wire from catching when pushed forward. Designed for use with the Castroviejo Snare (E3675). Package of 12 stainless steel wires. Overall length 4.3 inches....
Open ring design for globe fixation during various ocular procedures. Blunt fixation points. Swivel handle provides increased flexibility. Manufactured in titanium....
Open ring design for globe fixation during various ocular procedures. Blunt fixation points. Swivel handle provides increased flexibility. Manufactured in titanium....
Open 14 mm fixation ring with teeth to prevent damage to conjuctiva. Gauge is marked every 10 degrees to determine the extent of the arc to be incised. Two broad marks align with steep axis....
Medicine Products: